COMPANY

A growing business

We are an industry leader in producing plasma-derived medicines and transfusion medicine for patients around the world.

Our business is organized into four divisions: Bioscience, Diagnostic, Hospital and Bio Supplies.

We sell our products and services in more than 100 countries and have subsidiaries in 30 of them.

We aim to be a global leader in our markets and we continue to be an industry reference for quality, safety and innovation.

4.5
billion

revenue

21230
employees

291
million

R&D+i investments

4.5
billion

revenue

21230
employees

291
million

R&D+i investments

 

Grifols' history of growth demonstrates its capacity to evolve and make a positive impact on society. We take great pride in our ethical approach and work diligently to ensure the safety of our products."

Raimon Grífols, CEO

 

At Grifols, we think and act with a long-term, sustainable and responsible perspective at every stage of the value chain. We place donors and patients at the heart of our activities to improve people's well-being."

Víctor Grífols Deu, CEO